AQR Capital Management
PVLA

AQR Capital Management’s Palvella Therapeutics PVLA Stock Holding History

AQR Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-612
Closed -$126K – 2309
2021
Q1 		$126K Sell
612
-620
-50% -$136K ﹤0.01% 2147
2020
Q4 		$246K Sell
1,232
-304
-20% -$63.2K ﹤0.01% 2031
2020
Q3 		$254K Sell
1,536
-667
-30% -$152K ﹤0.01% 1979
2020
Q2 		$546K Sell
2,203
-57
-3% -$13.3K ﹤0.01% 1710
2020
Q1 		$412K Buy
2,260
+2,046
+956% +$516K ﹤0.01% 1655
2019
Q4 		$62K Buy
+214
New +$59.3K ﹤0.01% 2102
2019
Q3 		– Sell
-445
Closed -$167K – 2179
2019
Q2 		$167K Sell
445
-104
-19% -$31K ﹤0.01% 1996
2019
Q1 		$147K Sell
549
-1,105
-67% -$263K ﹤0.01% 2108
2018
Q4 		$352K Sell
1,654
-77
-4% -$23.9K ﹤0.01% 1906
2018
Q3 		$775K Sell
1,731
-803
-32% -$349K ﹤0.01% 1797
2018
Q2 		$1.03M Sell
2,534
-2,663
-51% -$1.27M ﹤0.01% 1709
2018
Q1 		$2.83M Buy
5,197
+2,132
+70% +$1.32M ﹤0.01% 1211
2017
Q4 		$1.85M Buy
3,065
+2,159
+238% +$1M ﹤0.01% 1412
2017
Q3 		$417K Buy
+906
New +$387K ﹤0.01% 1999

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AQR Capital Management's PVLA Position: Q2 2021 in Review

AQR Capital Management sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 612 shares — an estimated $126K sold.

AQR Capital Management first reported a position in PVLA in Q3 2017 and held it in 14 quarters. The position peaked at $2.83M in Q1 2018. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.

  • AQR Capital Management reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
  • AQR Capital Management sold 612 Palvella Therapeutics shares in Q2 2021, an estimated $126K.
  • AQR Capital Management first reported a position in Palvella Therapeutics in Q3 2017 and held it in 14 quarters.
  • AQR Capital Management's Palvella Therapeutics position peaked at $2.83M in Q1 2018.
  • 73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.

Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.